// App-Quantinova.ai

204 : Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Researchers

Presenter

  • Ang Li

Principal Investigators

  • Jeremy L. Warner

  • Aakash Desai

  • Dimpy P. Shah

  • Julie Fu

  • Monica Li

  • Rebecca Zon

  • Surbhi Shah

  • Shuchi Gulati

  • Ali Raza Khaki

  • Amit Kulkarni

  • Amro Elshoury

  • Michael A. Thompson

  • Petros Grivas

  • Gilberto de Lima Lopes

  • Yu Shyr

  • Nathan A Pennell

  • Andrew Schmidt

  • Christopher R Friese

  • Daniel Stover

  • Jaymin Patel

  • Balazs Halmos

  • Toni K. Choueiri

  • Solange Peters

  • Donna R. Rivera

  • Corrie Painter

  • Brian Rini

  • Gary H. Lyman

  • Jean M. Connors

  • Rachel P. Rosovsky

Medical Centers

  • Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX

  • Advanced Cancer Research Group, Seattle, WA

  • Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN

  • Department of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

  • Mays Cancer Center at UT Health San Antonio MD Anderson Cencer Center,San Antonio, TX,Stati Uniti

  • Tufts Medical Center, Boston, MA

  • The Dan L Duncan Comprehensive Cancer at Baylor College of Medicine, Houston, TX

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • University of Minnesota, Minneapolis, MN

  • University Of Cincinnati Barrett Cancer Ctr, Cincinnati, OH

  • Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI

  • Fred Hutchinson Cancer Research Center/University of Washington/Seattle Cancer Care Alliance, Seattle

  • Sylvester Comprehensive Cancer Center at Univ of Miami, Miami, FL

  • Vanderbilt University School of Medicine, Nashville, TN

  • Lung Program, Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Michigan, Ann Arbor, MI

  • Ohio State University Wexner Medical Center, Columbus, OH

  • Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA

  • Montefiore Medical Center, Bronx, NY

  • Dana-Farber Cancer Institute, Boston, MA

  • Lausanne University Hospital, Lausanne, Switzerland

  • National Cancer Institute, Bethesda, MD

  • Cancer Program, Broad Institute, Cambridge, MA

  • Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA

  • Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA

Locations

  • United States

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

  • Obesity

  • Solid malignancies

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • NCT04354701

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved